Immunosuppression Withdrawal in Patients with Lupus Nephritis: When, How, and for Whom Will It Be Safe?

Autor: Frangou E; Department of Nephrology, Limassol General Hospital, State Health Services Organization, Limassol, Cyprus.; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus., Anders HJ; Division of Nephrology, Department of Internal Medicine IV, Hospital of the Ludwig-Maximilians-University, Munich, Germany., Bajema IM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, The Netherlands., Teng YKO; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic Disease (LuVaCs), Department of Internal Medicine - Section Nephrology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands., Malvar A; Nephrology Unit, Hospital Fernandez, Buenos Aires, Argentina., Rovin BH; Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Kronbichler A; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
Jazyk: angličtina
Zdroj: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2024 Jul 01; Vol. 35 (7), pp. 955-958. Date of Electronic Publication: 2024 Apr 09.
DOI: 10.1681/ASN.0000000000000365
Databáze: MEDLINE